c-Met downregulation contributes to Metformin-induced inhibition of MDA-MB-468 triple negative breast cancer cells

被引：0
|
作者：
Gant, Dana M. [1 ]
Ma, Zhikun [1 ]
Parris, Amanda B. [1 ]
Yang, Xiaohe [1 ]
机构：
[1] North Carolina Cent Univ, Durham, NC USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1123
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Formononetin Enhances the Tumoricidal Effect of Everolimus in Breast Cancer MDA-MB-468 Cells by Suppressing the mTOR Pathway
    Zhou, Qianmei
    Zhang, Weihong
    Li, Tian
    Tang, Runwei
    Li, Chaoran
    Yuan, Shuai
    Fan, Desheng
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2019, 2019
  • [42] EPIDERMAL GROWTH FACTOR-MEDIATED APOPTOSIS OF MDA-MB-468 HUMAN BREAST-CANCER CELLS
    ARMSTRONG, DK
    KAUFMANN, SH
    OTTAVIANO, YL
    FURUYA, Y
    BUCKLEY, JA
    ISAACS, JT
    DAVIDSON, NE
    CANCER RESEARCH, 1994, 54 (20) : 5280 - 5283
  • [43] Janus kinases and Src family kinases in the regulation of EGF-induced vimentin expression in MDA-MB-468 breast cancer cells
    Stewart, Teneale A.
    Azimi, Iman
    Brooks, Andrew J.
    Thompson, Erik W.
    Roberts-Thomson, Sarah J.
    Monteith, Gregory R.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2016, 76 : 64 - 74
  • [44] Inhibition of IGF signalling pathway in MDA-MB-231 triple negative breast cancer cells
    S Chandran
    JH Harmey
    S Toomey
    BMC Proceedings, 6 (Suppl 4)
  • [45] Targeting c-Met in triple negative breast cancer: preclinical studies using the c-Met inhibitor, Cpd A
    Breen, Laura
    Gaule, Patricia B.
    Canonici, Alexandra
    Walsh, Naomi
    Collins, Denis M.
    Cremona, Mattia
    Hennessy, Bryan T.
    Duffy, Michael J.
    Crown, John
    O' Donovan, Norma
    Eustace, Alex J.
    INVESTIGATIONAL NEW DRUGS, 2020, 38 (05) : 1365 - 1372
  • [46] Targeting c-Met in triple negative breast cancer: preclinical studies using the c-Met inhibitor, Cpd A
    Laura Breen
    Patricia B. Gaule
    Alexandra Canonici
    Naomi Walsh
    Denis M. Collins
    Mattia Cremona
    Bryan T. Hennessy
    Michael J. Duffy
    John Crown
    Norma O’ Donovan
    Alex J. Eustace
    Investigational New Drugs, 2020, 38 : 1365 - 1372
  • [47] KNOCKDOWN OF TRIM66 IN MDA-MB-468 TRIPLE NEGATIVE BREAST CANCER CELL LINE SUPPRESSES PROLIFERATION AND PROMOTES APOPTOSIS THROUGH EGFR SIGNALING
    Zhang, Huayi
    Zheng, Yaqin
    Zhang, Yongmei
    POLISH JOURNAL OF PATHOLOGY, 2021, 72 (02) : 160 - 166
  • [48] Characterization of functional heterogeneity and in vivo dynamics of clonal cell populations derived from the triple-negative breast cancer cell line MDA-MB-468
    Kuiken, Hendrik J.
    Dhakal, Sabin
    Selfors, Laura M.
    Crowdis, Jett P.
    Bhang, Hyo-eun C.
    Stegmeier, Frank
    Mills, Gordon B.
    Brugge, Joan S.
    CANCER RESEARCH, 2017, 77
  • [49] Functional Elucidation and Methylation-Mediated Downregulation of ITGA5 Gene in Breast Cancer Cell Line MDA-MB-468
    Fang, Zhengyu
    Yao, Wantong
    Xiong, Yi
    Zhang, Jufeng
    Liu, Li
    Li, Jiana
    Zhang, Chao
    Wan, Jun
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2010, 110 (05) : 1130 - 1141
  • [50] Cell Cycle Effects of Iniparib, a PARP Inhibitor, in Combination with Gemcitabine and Carboplatin in the MDA-MB-468(-) Triple-Negative Breast Cancer (TNBC) Cell Line
    Ossovskaya, V.
    Lim, C-U
    Schools, G.
    Kalurupalle, S.
    Roninson, I. B.
    Broude, E.
    CANCER RESEARCH, 2010, 70
12345